AbbVie (NYSE: ABBV) and Fighting Blindness Canada have launched the Glaucoma in Perspective (GiP) app to help Canadians understand the impact of glaucoma and manage disease progression. The launch of GiP coincides with World Sight Day, as the vision loss community comes together to raise awareness and understanding of eye diseases like glaucoma.
GiP was developed based on research and insights into patients’ perception of sight loss with glaucoma. The app provides users with guidance on treatment regimen and includes a series of interactive demonstrations to encourage at-risk individuals to seek early intervention from a healthcare professional by allowing them to experience the impact of glaucoma on everyday situations. It also provides information on available treatment options to support glaucoma management.
The GiP app is now available at the App Store and Google Play for free.
Glaucoma affects more than 728,000 Canadians and takes the form of several related disease types, the most common being open angle glaucoma.1 Glaucoma is characterized by a build-up of aqueous humour fluid and increased intraocular pressure (IOP) that damages the optic nerve.2 There is no cure for glaucoma, but early detection and treatment can help prevent damage to the optic nerve, and as a result, save vision.3
In a national survey of 150 respondents with glaucoma, 69% of respondents didn’t know what type of glaucoma they have. 65% of respondents relied on their doctor’s office for new resources and information to support their glaucoma knowledge while 39% search online.4
Apple
